Vanda Pharmaceuticals | VNDA - 销售成本



金融业
股票价格
USD
资产
USD 488.95M
现金及等价物
USD 84.85M
销售成本
USD 198.77M
流动资产
USD 347.26M
流动负债
USD 145.16M
债务
USD 4.96M
股息收益率
0
EBIT
USD -10.28M
EBITDA
USD -8.31M
员工
203
EPS每股收益
USD -0.09
股本和储备
USD 327.19M
销售毛利
USD 50.6M
债务利息支出
-1.37B
贷款资金
USD 3.15M
市值
USD 357.3M
净收入
USD -18.9M
营业费用
USD -1.14B
营业利润
USD -40.66M
普通股股本
USD 58K
PE价格收益
16.79
税前利润
USD -22.92M
销售收入
USD 198.77M
销售和管理费用
USD 39.28M
股票
USD 1.85M
贸易债权人
USD 39.09M
应收帐款人
USD 47.1M


销售成本 更改 日
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Akebia Therapeutics USD 10.34M 441K 2025-12
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 49.5M 3.34M 2026-03
J&J USD 8.07B 103M 2026-03
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Ligand Pharmaceuticals USD 11.37M 8.38M 2026-03
Merck USD 2.94B 380M 2026-03
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 955M 503M 2026-03
Novartis USD 3.54B 7M 2025-12
Pfizer USD 4.59B 1.7B 2026-03
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 3.67B 621M 2026-03
Takeda JPY 560.54B 159.39B 2026-03
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Veracyte USD 38.49M 794K 2026-03